COMPARISON OF PERCUTANEOUS CORONARY INTERVENTION AND CORONARY ARTERY BYPASS GRAFTING FOR REVASCULARIZATION OF PATIENTS WITH DIABETES MELLITUS  by Stub, Dion et al.
    
  i2 SUMMIT   
E1895
JACC April 5, 2011
Volume 57, Issue 14
COMPARISON OF PERCUTANEOUS CORONARY INTERVENTION AND CORONARY ARTERY BYPASS 
GRAFTING FOR REVASCULARIZATION OF PATIENTS WITH DIABETES MELLITUS
i2 Poster Contributions
Ernest N. Morial Convention Center, Hall F
Monday, April 04, 2011, 3:30 p.m.-4:45 p.m.
Session Title: PCI - Complex Patients, Diabetes, Renal Insufficiency
Abstract Category: 13. PCI - Complex Patients, Diabetes, Renal Insufficiency
Session-Poster Board Number: 2512-535
Authors: Dion Stub, William Chan, Nick Andrianopoulos, Michelle Butler, David J. Clark, Andrew E. Ajani, Angela Brennan, Andrew E. Newcomb, 
Julian A. Smith, Pratyusha Naidu, Anthony M. Dart, Diem T. Dinh, Stephen J. Duffy, Monash Centre of Cardiovascular Research and Education in 
Therapeutics (CCRE), Monash University, Melbourne, Australia, Heart Centre Alfred Hospital
Introduction Sub-group analyses of several randomised controlled trials of percutaneous coronary intervention (PCI) versus coronary artery bypass 
grafting (CABG) suggest that diabetics with multivessel coronary artery disease (CAD) have improved event-free survival with CABG.
Method We compared clinical characteristics and long-term mortality using National Death Index data in 3455 patients with diabetes who 
underwent PCI (n=1112; 32%) or CABG (n=2343; 68%) in two large, parallel, multi-centre registries from April 2004 to October 2008. Cardiogenic 
shock, acute myocardial infarction (MI) <24 hours, previous CABG, associated valve surgery or prior PCI were exclusions. Predictors of long-term 
mortality were determined using Cox proportional hazard modelling.
Results Both PCI and CABG groups had similar age, ejection fraction and BMI. Patients undergoing CABG were more likely to be males, 
dyslipidaemic, hypertensive, have cerebrovascular, and peripheral arterial disease, prior MI, heart failure, higher intra-aortic balloon pump use, and 
multivessel CAD (all p<0.0001). By contrast, more PCI patients had recent MI (1-7 days prior), NYHA class IV symptoms, creatinine >200μmol/L, and 
were current smokers (all p≤0.02). Over 2.2 years of follow up, mortality was similar between the CABG and PCI cohorts (6.0% vs. 5.4%, p=0.47). 
Significant multivariate predictors of mortality included age (HR 1.05 per year; 95% CI 1.03-1.06, p<0.0001), creatinine (4.3; 2.9-6.4, p<0.0001), 
IABP use (3.0; 1.7-5.3, p<0.0001) and prior MI (1.5; 1.1-2.1, p=0.01), but not the mode of revascularisation (0.99; 0.7-1.5, p=0.94).
Conclusion In this multi-centre, real world registry of patients with diabetes requiring revascularization, CABG and PCI provide comparable 
mortality benefit.
